Comparing the effect of induction therapy with or without antithymocyte globulin on renal allograft outcomes in live-donor kidney transplant recipients

机译：比较有或没有抗胸腺细胞球蛋白的诱导疗法对活体供肾肾移植受者肾同种异体移植结果的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study aimed to investigate the effectiveness of antithymocyte globulin (ATG) in low-risk live-donor kidney transplant recipients (LDKTRs).

机译：这项研究旨在调查抗胸腺细胞球蛋白（ATG）在低危活体肾移植受者（LDKTRs）中的有效性。

著录项

期刊名称 Medical Journal of the Islamic Republic of Iran
作者
Bahareh Marghoob; Neda Rahimian; Yousef Ataiepour; Marziyeh Mahdifarani; Masoumeh Nejatifar; Ali Kabir;
展开▼
作者单位

展开▼
年(卷),期 2019(33),-1
年度 2019
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类
关键词
Antithymocyte Globulin; Kidney Transplantation; Living Donors; Creatinine; Survival;

机译：抗胸腺细胞球蛋白;肾脏移植;活体供体;肌酐;生存;

相似文献

外文文献
中文文献
专利

1. Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin. [J] . Thibaudin D, Alamartine E, de-Filippis JP, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 1998,第3期

机译：抗胸腺细胞球蛋白诱导在致敏肾受体中的优势：一项随机前瞻性研究，比较了有和没有抗胸腺细胞球蛋白的诱导。
2. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. [J] . Charpentier B, Rostaing L, Berthoux F, Transplantation: Official Journal of the Transplantation Society . 2003,第6期

机译：一项三臂研究比较了成人肾移植受者中立即他克莫司疗法与抗胸腺细胞球蛋白诱导疗法，他克莫司或环孢素A的疗效。
3. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes [J] . Trofe-ClarkJ., ReeseP.P., PatelH.J., Transplantation: Official Journal of the Transplantation Society . 2012,第5期

机译：延长从头至尾门诊兔抗胸腺细胞球蛋白在从头移植肾患者中的疗效和安全性：6个月的结局
4. Anti-Thymocyte-Globulin (ATG-Fresenius) for Prevention of Acute and Chronic Graft-versus-Host Disease in Pediatric and Adult Recipients of Unrelated Donor Bone Marrow Transplantation [C] . . 2006

机译：抗胸腺细胞球蛋白（ATG-Fresenius）预防无关供体骨髓移植的小儿和成年患者的急性和慢性移植物抗宿主病
5. A Retrospective Analysis of Renal Transplant Outcomes: induction Immunosuppression with Anti-thymocyte Globulin vs. Alemtuzumab in patients undergoing Deceased and Living Donor Kidney Transplantation. [D] . DiMartino, Debra A. 2012

机译：肾移植结果的回顾性分析：死者和活体供者肾脏移植患者中抗胸腺细胞球蛋白与Alemtuzumab的诱导免疫抑制作用。
6. Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation [O] . Hoa Le Mai, Michèle Treilhaud, Shani Leviatan Ben-Arye, 2018

机译：非肾器官移植后肾移植受者抗胸腺细胞球蛋白诱导治疗后患者和移植结果差
7. Comparing the effect of induction therapy with or without antithymocyte globulin on renal allograft outcomes in live-donor kidney transplant recipients [O] . Bahareh Marghoob, Neda Rahimian, Yousef Ataiepour, 2019

机译：对诱导治疗在患者肾移植受者肾同种异体移植接受者中的诱导治疗对肾同种异体移植蛋白的影响

Comparing the effect of induction therapy with or without antithymocyte globulin on renal allograft outcomes in live-donor kidney transplant recipients

摘要

著录项

相似文献

相关主题

期刊订阅